positions available now

Category Archives: PBAC

Ready? Get Set…Go! Planning the most appropriate strategy for your product to enter the Australian market

As we weave our way through life, we plan…plan our career, plan our finances, plan a holiday and most of us would have at least once in our lifetime planned a party. The key to a successful plan is finding … Continue reading

Posted in Life Sciences Industry, Market Access, PBAC, Regulatory Services, TGA | Tagged , | Comments Off on Ready? Get Set…Go! Planning the most appropriate strategy for your product to enter the Australian market

Multi-criteria decision making – How can non-health attributes be considered and valued?

Pressure is mounting on decisions to recommend and continue funding health technologies. Concerns around the rising cost of new medicines, an ageing population with greater resource utilisation, federal and state healthcare budgetary constraints, and an increasing dependency ratio (the ratio … Continue reading

Posted in Life Sciences Industry, Market Access, PBAC | Tagged | Comments Off on Multi-criteria decision making – How can non-health attributes be considered and valued?

The PBAC major submission deadline is nearly here. Are you prepared for lodgement?

With the March 2016 major submission deadline looming, a significant but commonly overlooked aspect are the key administrative documents that accompany a lodged submission.  With a number of key documents changing, either in new process or content, as well as … Continue reading

Posted in E-Health/Technology, Market Access, PBAC | Tagged , | Comments Off on The PBAC major submission deadline is nearly here. Are you prepared for lodgement?

Pricing uncertainty within the Pharmaceutical Benefits Scheme

Recent years have seen an active attempt to control Pharmaceutical Benefits Scheme (PBS) costs. Price disclosure and mandatory price cuts upon formulary transition have ensured prices of pharmaceuticals (especially generics) continue to tumble. Yet despite the use of these tools, … Continue reading

Posted in Life Sciences Industry, Market Access, PBAC, PBS | Tagged , | Comments Off on Pricing uncertainty within the Pharmaceutical Benefits Scheme

Defining value in the MBS Review

In May 2015 the Federal Government announced a review of the Medicare Benefits Schedule (MBS) with a view to bringing the MBS up-to-date and increase the value derived from the more than 5,700 listed items. The announcement of this review … Continue reading

Posted in Market Access, MBS, Medicare Benefits Schedule, MSAC, PBAC, PBS | Tagged , , , , , , | Comments Off on Defining value in the MBS Review

Is it possible to manage PBS Managed Entry Schemes?

Flash back to 1st January 2011 and the Department of Health introduced a unique market access route for innovative medicines to be listed on the PBS: the Managed Entry Scheme. The original framework for the introduction of a PBS Managed … Continue reading

Posted in Life Sciences Industry, Market Access, PBAC, PBS | Comments Off on Is it possible to manage PBS Managed Entry Schemes?
Copyright © 2014 Commercial Eyes